- Home
- FE vs CRNX Comparison
FE vs CRNX Comparison
Compare FE & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FE
- CRNX
- Stock Information
- Founded
- FE 1996
- CRNX 2008
- Country
- FE United States
- CRNX United States
- Employees
- FE N/A
- CRNX N/A
- Industry
- FE Electric Utilities: Central
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- FE Utilities
- CRNX Health Care
- Exchange
- FE Nasdaq
- CRNX Nasdaq
- Market Cap
- FE N/A
- CRNX 2.8B
- IPO Year
- FE N/A
- CRNX 2018
- Fundamental
- Price
- FE $39.76
- CRNX $30.48
- Analyst Decision
- FE Buy
- CRNX Strong Buy
- Analyst Count
- FE 15
- CRNX 10
- Target Price
- FE $46.15
- CRNX $75.00
- AVG Volume (30 Days)
- FE 5.6M
- CRNX 654.7K
- Earning Date
- FE 07-30-2025
- CRNX 08-07-2025
- Dividend Yield
- FE 4.46%
- CRNX N/A
- EPS Growth
- FE 1.45
- CRNX N/A
- EPS
- FE 1.88
- CRNX N/A
- Revenue
- FE $13,764,000,000.00
- CRNX $760,000.00
- Revenue This Year
- FE $9.20
- CRNX $402.12
- Revenue Next Year
- FE $3.82
- CRNX $770.88
- P/E Ratio
- FE $21.22
- CRNX N/A
- Revenue Growth
- FE 8.03
- CRNX N/A
- 52 Week Low
- FE $37.58
- CRNX $24.10
- 52 Week High
- FE $44.97
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- FE 40.95
- CRNX 50.56
- Support Level
- FE $39.34
- CRNX $28.98
- Resistance Level
- FE $39.99
- CRNX $30.34
- Average True Range (ATR)
- FE 0.49
- CRNX 1.11
- MACD
- FE 0.03
- CRNX -0.01
- Stochastic Oscillator
- FE 30.43
- CRNX 66.46
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.